Memory T cells and sepsis severity study
Part of Infections clinical trials.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have sepsis (a serious infection that affects your whole body).
- You have not taken strong sedatives before joining the study.
- You or your family agree to take part in the study.
- You do not have a history of organ or bone marrow transplant.
- You do not have an autoimmune disease (like rheumatoid arthritis or lupus) or a blood cancer (like leukemia or lymphoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.